Azathioprine versus MMF in renal transplant
Phase 4
- Conditions
- Health Condition 1: null- Renal Transplant
- Registration Number
- CTRI/2018/02/012003
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adults of either sex undergoing their first living donor renal transplant
2.Willing to sign informed consent.
Exclusion Criteria
1. Sensitised patients
2. Pregnant or Nursing mothers
3. Patients suffering from any malignancy requiring immediate surgery, ongoing chemotherapy or radiation,
4. Patients with untreated hypercholesterolemia defined as having total cholesterol >200 mg/dl, triglycerides > 300mg/dL, 5. Patient having significant liver disease defined as having during the past 30 days continuously elevated SGOT and or SGPT levels greater than 3 times the upper value of normal range, patients suffering from severe diarrhoea, vomiting, GI malabsorption or active peptic ulcer disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute RejectionTimepoint: 6 and 12 months
- Secondary Outcome Measures
Name Time Method Graft loss, estimated glomerular filtration rate and adverse eventsTimepoint: 6 and 12 months